Ginkgo Bioworks DNA Stock
Ginkgo Bioworks Price Chart
Ginkgo Bioworks DNA Financial and Trading Overview
| Ginkgo Bioworks stock price | 8.73 USD |
| Previous Close | 9.37 USD |
| Open | 9.17 USD |
| Bid | 9.07 USD x 20000 |
| Ask | 9.11 USD x 10000 |
| Day's Range | 8.89 - 9.35 USD |
| 52 Week Range | 5.37 - 17.58 USD |
| Volume | 953.81K USD |
| Avg. Volume | 1.22M USD |
| Market Cap | 597.07M USD |
| Beta (5Y Monthly) | 1.779 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -5.38 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 8.5 USD |
DNA Valuation Measures
| Enterprise Value | 649.33M USD |
| Trailing P/E | N/A |
| Forward P/E | -2.847352 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 3.9436576 |
| Price/Book (mrq) | 1.2717407 |
| Enterprise Value/Revenue | 4.289 |
| Enterprise Value/EBITDA | -2.474 |
Trading Information
Ginkgo Bioworks Stock Price History
| Beta (5Y Monthly) | 1.779 |
| 52-Week Change | 31.41% |
| S&P500 52-Week Change | 27.69% |
| 52 Week High | 17.58 USD |
| 52 Week Low | 5.37 USD |
| 50-Day Moving Average | 7.82 USD |
| 200-Day Moving Average | 9.65 USD |
DNA Share Statistics
| Avg. Volume (3 month) | 1.22M USD |
| Avg. Daily Volume (10-Days) | 943.77K USD |
| Shares Outstanding | 53.36M |
| Float | 47.85M |
| Short Ratio | 3.4 |
| % Held by Insiders | 4.59% |
| % Held by Institutions | 68.65% |
| Shares Short | 4.52M |
| Short % of Float | 8.76% |
| Short % of Shares Outstanding | 6.92% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:40 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | -201.054% |
| Operating Margin (ttm) | -366.50% |
| Gross Margin | 69.62% |
| EBITDA Margin | -173.37% |
Management Effectiveness
| Return on Assets (ttm) | -16.15% |
| Return on Equity (ttm) | -56.027% |
Income Statement
| Revenue (ttm) | 151.4M USD |
| Revenue Per Share (ttm) | 2.67 USD |
| Quarterly Revenue Growth (yoy) | -49.10% |
| Gross Profit (ttm) | 105.42M USD |
| EBITDA | -262492992 USD |
| Net Income Avi to Common (ttm) | -305512000 USD |
| Diluted EPS (ttm) | -5.38 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 373.46M USD |
| Total Cash Per Share (mrq) | 5.72 USD |
| Total Debt (mrq) | 410.7M USD |
| Total Debt/Equity (mrq) | 92.68 USD |
| Current Ratio (mrq) | 5.151 |
| Book Value Per Share (mrq) | 7.187 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -166224000 USD |
| Levered Free Cash Flow (ttm) | -77930000 USD |
Profile of Ginkgo Bioworks
| Country | United States |
| State | MA |
| City | Boston |
| Address | 27 Drydock Avenue |
| ZIP | 02210 |
| Phone | 877 422 5362 |
| Website | https://www.ginkgo.bio |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 485 |
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell engineering in the United States. It operates through the Cell Engineering and Biosecurity segments. The company offers cell engineering research and development solutions, as well as cell engineering tools comprising functional genomics, antibody developability, and small molecule developability, artificial intelligence models, and reconfigurable automation cart systems on its platform for use in the research, development, and commercialization of engineered organisms and derived products. It also provides biomonitoring and bioinformatics support services through Canopy, which generates genomic data from strategically positioned nodes through biomonitoring programs; and Horizon, a digital surveillance, analytics, and insights platform that detects and monitors biothreats. In addition, the company offers genetic medicine R&D, protein engineering, bioprocess development, crop nutrition and protection solutions, and plant trait optimization. The company serves pharmaceutical and biotechnology, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
Q&A For Ginkgo Bioworks Stock
What is a current DNA stock price?
Ginkgo Bioworks DNA stock price today per share is 8.73 USD.
How to purchase Ginkgo Bioworks stock?
You can buy DNA shares on the NYSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Ginkgo Bioworks?
The stock symbol or ticker of Ginkgo Bioworks is DNA.
Which industry does the Ginkgo Bioworks company belong to?
The Ginkgo Bioworks industry is Biotechnology.
How many shares does Ginkgo Bioworks have in circulation?
The max supply of Ginkgo Bioworks shares is 65.32M.
What is Ginkgo Bioworks Price to Earnings Ratio (PE Ratio)?
Ginkgo Bioworks PE Ratio is now.
What was Ginkgo Bioworks earnings per share over the trailing 12 months (TTM)?
Ginkgo Bioworks EPS is -5.38 USD over the trailing 12 months.
Which sector does the Ginkgo Bioworks company belong to?
The Ginkgo Bioworks sector is Healthcare.
Ginkgo Bioworks DNA included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| US Tech US 700 Small Cap Index NQUS700SC | 2992.49 USD — |
-1.38
|
— — | 2986.86 USD — | 3018.97 USD — | — - | — — |
| US Tech CRB Monitor Global Canna HERBALAUNR | 142.78 AUD 94.5 USD |
-0.41
|
— — | 142.5 AUD 94.31 USD | 144.26 AUD 95.48 USD | — - | — — |
| NYSE Composite Index NYA | 23276.49 USD — |
-0.87
|
— — | 23276.49 USD — | 23480.92 USD — | — - | — — |
| US Tech AlphaDEX Multi Cap Growt NQDXUSMLTCG | 4054.02 USD — |
-0.25
|
— — | 4019.75 USD — | 4077 USD — | — - | — — |
| US Tech CRB Monitor Global Canna HERBAL | 118.96 USD — |
-0.74
|
— — | 118.67 USD — | 120.12 USD — | — - | — — |
- {{ link.label }} {{link}}